Drugs / LY3872386
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06119529 | Nov 2023 → Apr 2024 | atopic eczema | Eli Lilly and Company | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY3872386 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06119529 ↗ |
| Route | Intravenous | “administered intravenously (IV)” NCT06119529 ↗ |